RxDoctor Payments Data

Andrew Karpenko, MD

Otolaryngology · Monroe, MINPI 1447350780

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $7,049 of the $9,511 with a category attached, or 74.1%. 27 manufacturers reported payments, led by Intersect ENT, Inc. at 28.4% of the total.

$9,511in general payments, 2019–2025

Across 331 payments — averaging $28.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intersect ENT, Inc.$3K
  • Jazz Pharmaceuticals Inc.$1K
  • Regeneron Healthcare Solutions, Inc.$865
  • Optinose US, Inc.$827
  • Sanofi$757
  • Harmony Biosciences LLC$703
  • plus $2K from 21 others

What the payments were for

  • Consulting fees$3504%
  • Travel & lodging$1,70218%
  • Food & beverage$7,04974%
  • Education$4104%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,511 in reported general payments places this provider in the 85th percentile of 257 otolaryngology providers in Michigan.

See all otolaryngology providers in Michigan

Medicare billing

Part B allowed, 2024
$131,722
Medicare patients
641
Services billed
1,496

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XywavSodium,calcium,mag,pot Oxybate11$213,894
Cevimeline Hcl17$5,315
Fluticasone Propionate228$5,194
Ipratropium Bromide102$4,864
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth21$2,613
Famotidine63$1,389
Nystatin52$1,143
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip108$1,097
Mupirocin190$1,048
Lansoprazole19$816
Montelukast Sodium47$576
Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid36$569
Cefdinir30$434
Clindamycin Hcl38$365
Omeprazole17$333

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Monroe

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →